UBE2C and central nervous system cancer: The immunohistochemical staining revealed that all the NHB tissues displayed no or extremely low levels of UBE2C protein expression (IRS ≦2, 27/27); however, 63% of the glioma tissues (97/154) exhibited strong UBE2C immunoreactivity (IRS ≧4).